Azathioprine-induced Myelotoxicity after Switching Mesalazine Compound

Marieke C. Barnhoorn*, Bert N. Storm, Nanne K. de Boer, Michael M. P. J. A. van der Voorn

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)E114-E115
JournalInflammatory Bowel Diseases
Issue number9
Publication statusPublished - 1 Sep 2021

Cite this